Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
ELAN Stock Chart & Stats
$21.52
-$0.30(-2.54%)
At close: 4:00 PM EST
$21.52
-$0.30(-2.54%)
Day’s Range― - ―
52-Week Range$8.02 - $22.98
Previous CloseN/A
Volume2.53M
Average Volume (3M)5.42M
Market Cap
$10.73B
Enterprise Value$13.52B
Total Cash (Recent Filing)$505.00M
Total Debt (Recent Filing)$4.02B
Price to Earnings (P/E)295.2
Beta1.42
Next Earnings
Feb 25, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding496,813,700
10 Day Avg. Volume6,263,194
30 Day Avg. Volume5,422,493
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)0.98
Price to Sales (P/S)1.35
P/FCF Ratio15.18
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue2.95
Enterprise Value/Gross Profit6.35
Enterprise Value/Ebitda15.18
Forecast
1Y Price Target
$23.83Price Target Upside10.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)0.91
Revenue Forecast (FY)$4.63B
Bulls Say, Bears Say
Bulls Say
Innovation And Product LaunchesThe Elanco story is changing for the better, as the company's new products have resonated quickly, leading to a faster growth rate and notable stock appreciation.
Market Position And Growth ExpectationsElanco's stock currently trades at a premium to Zoetis and is expected to grow faster in 2025 relative to the market leader, with significant margin expansion opportunities.
Revenue And Margin ExpansionRevenue contribution from the higher gross margin Innovation segment should remain robust, supporting both GM expansion and operating expense leverage.
Bears Say
Guidance And Market ChallengesManagement laid out potential headwinds for the upcoming year, including U.S. vet visit volume declines and competitive pressures from companies like Merck.
Market CompetitionThe backdrop could become more challenging due to potential new entrants in the market.
Product Safety ConcernsThe black box remains on the label and still touches on safety concerns around vaccinations.
Elanco Animal Health News
ELAN FAQ
What was Elanco Animal Health’s price range in the past 12 months?
Elanco Animal Health lowest stock price was $8.02 and its highest was $22.98 in the past 12 months.
What is Elanco Animal Health’s market cap?
Elanco Animal Health’s market cap is $10.73B.
When is Elanco Animal Health’s upcoming earnings report date?
Elanco Animal Health’s upcoming earnings report date is Feb 25, 2026 which is in 109 days.
How were Elanco Animal Health’s earnings last quarter?
Elanco Animal Health released its earnings results on Nov 05, 2025. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.06.
Is Elanco Animal Health overvalued?
According to Wall Street analysts Elanco Animal Health’s price is currently Undervalued.
Does Elanco Animal Health pay dividends?
Elanco Animal Health does not currently pay dividends.
What is Elanco Animal Health’s EPS estimate?
Elanco Animal Health’s EPS estimate is 0.12.
How many shares outstanding does Elanco Animal Health have?
Elanco Animal Health has 496,813,700 shares outstanding.
What happened to Elanco Animal Health’s price movement after its last earnings report?
Elanco Animal Health reported an EPS of $0.19 in its last earnings report, beating expectations of $0.13. Following the earnings report the stock price went down -4%.
Which hedge fund is a major shareholder of Elanco Animal Health?
Currently, no hedge funds are holding shares in ELAN
Elanco Animal Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.83 (10.73% Upside)
$23.83 (10.73% Upside)
Blogger Sentiment
Bullish
ELAN Sentiment 60%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 5.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.4%
Last 30 Days ▲ 71.5%
Last 30 Days ▲ 71.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.34%
12-Months-Change
Fundamentals
Return on Equity
0.54%
Trailing 12-Months
Asset Growth
2.02%
Trailing 12-Months
Company Description
Elanco Animal Health
Elanco Animal Health (ELAN) is a global leader in animal health, dedicated to advancing the health and well-being of pets and livestock. The company operates in two primary sectors: companion animals and food animals, providing a range of innovative products, including vaccines, parasiticides, antibiotics, and nutritional supplements. Elanco's mission is to enhance animal health through science-based solutions, ensuring better lives for animals and the people who care for them.
ELAN Company Deck
ELAN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Elanco reported strong financial results for Q3 2025 with significant revenue growth from both farm and pet health segments. The company achieved notable success with innovation products, particularly Credelio Quattro. However, challenges in pricing growth and tempered Bovaer adoption were noted. Overall, the sentiment is positive, driven by strong performance and strategic achievements.View all ELAN earnings summariesELAN Stock 12 Month Forecast
Average Price Target
$23.83
▲(10.73% Upside)
Technical Analysis
Dr Reddy's Laboratories
―
Viatris
―
Teva Pharmaceutical
―
Zoetis
―
Phibro Animal Health
―
Ownership Overview
0.97% Insiders
52.56% Mutual Funds
0.83% Other Institutional Investors
26.18% Public Companies and
Individual Investors